Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study

Radiotherapy and Oncology

Volumn 93, Issue 1, 2009, Pages 32-36

  Bates, Emma L ^a   Bragg, Christopher M ^a   Wild, Jim M ^b   Hatton, Matthew Q F ^a,b   Ireland, Rob H ^b  

^a WESTON PARK HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Hyperpolarized helium 3 MRI; Intensity modulated radiotherapy; Non small cell lung cancer; Radiotherapy treatment planning; SPECT

Indexed keywords

HELIUM;

ARTICLE; FUNCTIONAL ANATOMY; FUNCTIONAL IMAGE BASED RADIOTHERAPY PLANNING; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIMULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; TOTAL LUNG CAPACITY; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70349318355     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.05.018     Document Type: Article

References (22)

1. Rowell N.P., and Williams C.J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit or declining surgery (medically inoperable). Cochrane Database Syst Rev 2 (2001) CD002935
2. Jeremic B., Milicic B., Dagovic A., Acimovic L., and Milisavljevic S. Pretreatment prognostic factors in patients with early stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone. Int J Radiat Oncol Biol Phys 65 (2006) 1112-1119
3. Byhardt R.W., Scott C.B., Sause W.T., et al. Response, toxicity, failure patterns and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42 (1998) 469-478
4. Sause W., Kolesar P., Taylor IV S., et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117 (2000) 358-364
5. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumour control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung cancer 24 (1999) 31-37
6. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
7. Murshed H., Liu H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2003) 1258-1267
8. Liu H.H., Wang X., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1268-1279
9. Marks L.B., Spencer D.P., Sherhouse G.W., et al. The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram. Int J Radiat Oncol Biol Phys 33 (1995) 65-75
10. Seppenwoolde Y., Engelsman M., De Jaeger K., et al. Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol 63 (2002) 165-177
11. Lavrenkov K., Christian J.A., Partridge M., et al. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol 83 (2007) 156-162
12. Shioyama Y., Jang S.Y., Liu H.H., et al. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 1349-1358
13. Mcguire S.M., Zhou S., Marks L.B., Dewhurst M., Yin F.-F., and Das S.K. A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung. Int J Radiat Oncol Biol Phys 66 (2006) 1543-1552
14. Yaremko B.P., Guerrero T.M., Noyola-Martinez J., et al. Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance. Int J Radiat Oncol Biol Phys 68 (2007) 562-571
15. 3He MRI and 81mKr SPECT in chronic obstructive pulmonary disease. Eur J Nucl Med Mol Imaging 32 (2005) 448-457
16. Van Beek E.J., and Wild J.M. Hyperpolarized 3-helium magnetic resonance imaging to probe lung function. Proc Am Thorac Soc 2 (2005) 528-532
17. Christian J.A., Partridge M., Niotsikou E., et al. The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. Radiother Oncol 77 (2005) 271-277
18. Ireland R.H., Bragg C., McJury M., et al. Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 273-281
19. Lavrenkov K., Singh S., Christian J.A., et al. Effective avoidance of a functional SPECT-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study. Radiother Oncol 91 (2009) 349-352
20. Ireland R.H., Woodhouse N., Hoggard N., et al. An image acquisition and registration strategy for the fusion of hyperpolarized helium-3 MRI and X-ray CT images of the lung. Phys Med Biol 53 (2008) 6055-6063
21. Bragg C.M., Wingate K., and Conway J. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification. Radiother Oncol 86 (2008) 276-284
22. Saunders M., Dische S., Barrett A., Harvey A., Gibson D., and Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 350 (1997) 161-165